UI Pharmaceuticals has Non-Sterile Liquid and Semisolid Manufacturing and Testing Capabilities
University of Iowa Pharmaceuticals (UIP) offers pharmaceutical product development, manufacturing, and testing services for non-sterile liquids, creams, gels, and ointment products. Because UIP is registered with the FDA as a Drug Product Manufacturing and Testing Facility, we are able to produce and test products for both clinical studies and commercial sale. Let us help you meet your non-sterile liquid and semisolid manufacturing and testing needs.

UIP has three manufacturing suites: two suites are dedicated to the handling of potent/cytotoxic compounds and one suite is divided into four separate manufacturing rooms and is designed for handling less potent/toxic materials.
Each manufacturing room has its own gowning/entry way that opens from a central staging area.
Differential air pressures and single pass air, along with other measures including cleaning verification, are used to prevent cross-contamination.
Special protective suites, wireless intercoms and video feeds, and supplied air respirators are used to protect employees from exposure to potent/toxic materials.
The manufacturing area is supported with a clean, dry compressed air system and a hot loop USP Purified Water system.
All incoming air is HEPA filtered and humidity controlled and exhausted air is double HEPA filtered.
UIP can process controlled substances schedules I-V and most potent/cytotoxic compounds.
- Processing equipment includes a Tonazi tube filler and sealer, various overhead mixers, stainless steel tanks, and Hobart mixers equipped with counter-sweeps.
- Finished products can be filled into bottles, jars, or tubes or in bulk.
- Finished containers can be labeled. If desired, patient kits can be assembled and materials shipped directly to clinical sites for smaller trials.